Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Ligand Pharmaceuticals Incorporated”

124 pharma patents match "Ligand Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 124
Index total 30,257
Page 2 / 6

Quick answer

This filtered view shows 124 pharmaceutical patents matching "Ligand Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

124 results for “Ligand Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 9962370

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted May 8, 2018 · Expires May 3, 2038

    granted

  2. US 9676809

    Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

    Ligand Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  3. US 9675583

    Selective androgen receptor modulators (SARMS) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  4. US 9662312

    Method for treating glomerulosclerosis

    Ligand Pharmaceuticals Incorporated · Granted May 30, 2017 · Expires May 25, 2037

    granted

  5. US 9622991

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  6. US 9492430

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  7. US 9359285

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  8. US 9326991

    Nucleotide prodrug compounds and use

    Ligand Pharmaceuticals Incorporated · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  9. US 9266874

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  10. US 9144557

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  11. US 9139520

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  12. US 8865918

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  13. US 8822467

    Biaryl oxyacetic acid compounds

    Ligand Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  14. US 8748633

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  15. US 8680150

    Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

    Ligand Pharmaceuticals Incorporated · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  16. US 8580811

    Androgen receptor modulator methods

    Ligand Pharmaceuticals Incorporated · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  17. US 8519158

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  18. US 8354446

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  19. US 8193357

    Androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  20. US 7919248

    Methods for the modulation of IL-13

    Ligand Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  21. US 7816372

    6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  22. US 7727980

    Tricyclic androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  23. US 7696246

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  24. US 7691895

    Thrombopoietin activity modulating compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.